About the Authors
- Tina Falkeborn
-
Affiliation Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
- Andreas Bråve
-
Affiliation Swedish Institute for Communicable Disease Control (SMI), Stockholm, Sweden
- Marie Larsson
-
Affiliation Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
- Britt Åkerlind
-
Affiliation Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
- Ulf Schröder
-
Current address: Latorius AB, Sundbyberg, Sweden
Affiliation Eurocine Vaccines AB, Karolinska Science Park, Solna, Sweden
- Jorma Hinkula
-
* E-mail: jorma.hinkula@liu.se
Affiliations Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden, Eurocine Vaccines AB, Karolinska Science Park, Solna, Sweden
Competing Interests
Eurocine Vaccines AB have IP-rights and economical interests in the cationic adjuvants. J.H. and U.S. declare shareholdership in Eurocine Vaccines AB. The remaining authors declare no conflict of interest.
Author Contributions
Conceived and designed the experiments: JH ML US. Performed the experiments: TF JH. Analyzed the data: TF JH ML BÅ AB US. Contributed reagents/materials/analysis tools: JH AB BÅ US. Wrote the paper: TF JH ML BÅ US AB.